View in EDS HTML Full Text PDF Full Text

A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.

Saved in:
Bibliographic Details
Title: A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.
Authors: Heidenreich R; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Jasny E; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Kowalczyk A; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Lutz J; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Probst J; IDT Biologika GmbH, Quality Unit Vaccines, Dessau-Roßlau, Germany., Baumhof P; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Scheel B; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Voss S; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Kallen KJ; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany., Fotin-Mleczek M; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.
Source: International journal of cancer [Int J Cancer] 2015 Jul 15; Vol. 137 (2), pp. 372-84. Date of Electronic Publication: 2015 Jan 08.
Publication Type: Journal Article
Journal Info: Publisher: Wiley-Liss Country of Publication: United States NLM ID: 0042124 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-0215 (Electronic) Linking ISSN: 00207136 NLM ISO Abbreviation: Int J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 25530186
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Heidenreich+R%22">Heidenreich R</searchLink>; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.<br /><searchLink fieldCode="AU" term="%22Jasny+E%22">Jasny E</searchLink>; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.<br /><searchLink fieldCode="AU" term="%22Kowalczyk+A%22">Kowalczyk A</searchLink>; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.<br /><searchLink fieldCode="AU" term="%22Lutz+J%22">Lutz J</searchLink>; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.<br /><searchLink fieldCode="AU" term="%22Probst+J%22">Probst J</searchLink>; IDT Biologika GmbH, Quality Unit Vaccines, Dessau-Roßlau, Germany.<br /><searchLink fieldCode="AU" term="%22Baumhof+P%22">Baumhof P</searchLink>; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.<br /><searchLink fieldCode="AU" term="%22Scheel+B%22">Scheel B</searchLink>; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.<br /><searchLink fieldCode="AU" term="%22Voss+S%22">Voss S</searchLink>; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.<br /><searchLink fieldCode="AU" term="%22Kallen+KJ%22">Kallen KJ</searchLink>; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.<br /><searchLink fieldCode="AU" term="%22Fotin-Mleczek+M%22">Fotin-Mleczek M</searchLink>; CureVac GmbH, Department of pre-clinical research, Paul-Ehrlich-Str. 15, Tübingen, 72076, Germany.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220042124%22">International journal of cancer</searchLink> [Int J Cancer] 2015 Jul 15; Vol. 137 (2), pp. 372-84. <i>Date of Electronic Publication: </i>2015 Jan 08.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Liss%22">Wiley-Liss </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>0042124 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1097-0215 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200207136%22">00207136 </searchLink><i>NLM ISO Abbreviation: </i>Int J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=25530186
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/ijc.29402
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 372
    Titles:
      – TitleFull: A novel RNA-based adjuvant combines strong immunostimulatory capacities with a favorable safety profile.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Heidenreich R
      – PersonEntity:
          Name:
            NameFull: Jasny E
      – PersonEntity:
          Name:
            NameFull: Kowalczyk A
      – PersonEntity:
          Name:
            NameFull: Lutz J
      – PersonEntity:
          Name:
            NameFull: Probst J
      – PersonEntity:
          Name:
            NameFull: Baumhof P
      – PersonEntity:
          Name:
            NameFull: Scheel B
      – PersonEntity:
          Name:
            NameFull: Voss S
      – PersonEntity:
          Name:
            NameFull: Kallen KJ
      – PersonEntity:
          Name:
            NameFull: Fotin-Mleczek M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 15
              M: 07
              Text: 2015 Jul 15
              Type: published
              Y: 2015
          Identifiers:
            – Type: issn-electronic
              Value: 1097-0215
          Numbering:
            – Type: volume
              Value: 137
            – Type: issue
              Value: 2
          Titles:
            – TitleFull: International journal of cancer
              Type: main
ResultId 1